Luo Y, Liang H
Genome Med. 2024; 16(1):124.
PMID: 39468667
PMC: 11514945.
DOI: 10.1186/s13073-024-01393-6.
Xiong J, Zhou X, Su L, Jiang L, Ming Z, Pang C
Discov Oncol. 2024; 15(1):590.
PMID: 39453528
PMC: 11511804.
DOI: 10.1007/s12672-024-01464-5.
Khan M, Huang X, Ye X, Zhang D, Wang B, Xu A
Ann Med. 2024; 56(1):2405079.
PMID: 39387496
PMC: 11469424.
DOI: 10.1080/07853890.2024.2405079.
Ma Y, Huang Y, Hu F, Shu K
Int J Mol Med. 2024; 54(5).
PMID: 39301636
PMC: 11414527.
DOI: 10.3892/ijmm.2024.5426.
Afzal A, Afzal Z, Bizink S, Davis A, Makahleh S, Mohamed Y
Curr Issues Mol Biol. 2024; 46(8):7795-7811.
PMID: 39194679
PMC: 11352848.
DOI: 10.3390/cimb46080462.
Crosstalk between breast cancer-derived microRNAs and brain microenvironmental cells in breast cancer brain metastasis.
Khan M, Wong G, Zhuang C, Najjar M, Lo H
Front Oncol. 2024; 14:1436942.
PMID: 39175471
PMC: 11338853.
DOI: 10.3389/fonc.2024.1436942.
2-Methoxyestradiol, an Endogenous 17β-Estradiol Metabolite, Induces Antimitogenic and Apoptotic Actions in Oligodendroglial Precursor Cells and Triggers Endoreduplication via the p53 Pathway.
Schaufelberger S, Schaettin M, Azzarito G, Rosselli M, Leeners B, Dubey R
Cells. 2024; 13(13.
PMID: 38994940
PMC: 11240791.
DOI: 10.3390/cells13131086.
Causal effects of immune cells in glioblastoma: a Bayesian Mendelian Randomization study.
Huang M, Liu Y, Peng J, Cheng Y
Front Neurol. 2024; 15:1375723.
PMID: 38742049
PMC: 11089213.
DOI: 10.3389/fneur.2024.1375723.
Morphological differentiation of peritumoral brain zone microglia.
Salas-Gallardo G, Lorea-Hernandez J, Robles-Gomez A, Del Campo C, Pena-Ortega F
PLoS One. 2024; 19(3):e0297576.
PMID: 38451958
PMC: 10919594.
DOI: 10.1371/journal.pone.0297576.
Examining the function of macrophage oxidative stress response and immune system in glioblastoma multiforme through analysis of single-cell transcriptomics.
Xing J, Cai H, Lin Z, Zhao L, Xu H, Song Y
Front Immunol. 2024; 14:1288137.
PMID: 38274828
PMC: 10808540.
DOI: 10.3389/fimmu.2023.1288137.
The Traumatic Inoculation Process Affects TSPO Radioligand Uptake in Experimental Orthotopic Glioblastoma.
Gold L, Barci E, Brendel M, Orth M, Cheng J, Kirchleitner S
Biomedicines. 2024; 12(1).
PMID: 38255293
PMC: 10813339.
DOI: 10.3390/biomedicines12010188.
Flavonoid Rutin Presented Anti-Glioblastoma Activity Related to the Modulation of Onco miRNA-125b Expression and STAT3 Signaling and Impact on Microglia Inflammatory Profile.
Lima I, Soares E, Nonaka C, Souza B, Dos Santos B, Costa S
Brain Sci. 2024; 14(1).
PMID: 38248305
PMC: 10814059.
DOI: 10.3390/brainsci14010090.
MIF contribution to progressive brain diseases.
Matejuk A, Benedek G, Bucala R, Matejuk S, Offner H, Vandenbark A
J Neuroinflammation. 2024; 21(1):8.
PMID: 38178143
PMC: 10765708.
DOI: 10.1186/s12974-023-02993-6.
Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series.
Gurrieri L, Mercatali L, Ibrahim T, Fausti V, DallAgata M, Riva N
J Neurooncol. 2023; 164(1):55-64.
PMID: 37584750
PMC: 10462527.
DOI: 10.1007/s11060-023-04357-9.
CTLA-4 blockade induces a microglia-Th1 cell partnership that stimulates microglia phagocytosis and anti-tumor function in glioblastoma.
Chen D, Varanasi S, Hara T, Traina K, Sun M, McDonald B
Immunity. 2023; 56(9):2086-2104.e8.
PMID: 37572655
PMC: 11800830.
DOI: 10.1016/j.immuni.2023.07.015.
Macrophage's role in solid tumors: two edges of a sword.
Jahandideh A, Yarizadeh M, Masjedi M, Fatehnejad M, Jahandideh R, Soheili R
Cancer Cell Int. 2023; 23(1):150.
PMID: 37525217
PMC: 10391843.
DOI: 10.1186/s12935-023-02999-3.
A multimodal imaging-based classification for pediatric diffuse intrinsic pontine gliomas.
Pan C, Zhang M, Xiao X, Kong L, Wu Y, Zhao X
Neurosurg Rev. 2023; 46(1):151.
PMID: 37358632
DOI: 10.1007/s10143-023-02068-3.
Antisense oligonucleotide therapy for H3.3K27M diffuse midline glioma.
Zhang Q, Yang L, Liu Y, Wilkinson J, Krainer A
Sci Transl Med. 2023; 15(691):eadd8280.
PMID: 37043556
PMC: 10263181.
DOI: 10.1126/scitranslmed.add8280.
Targeting Glioblastoma-Associated Macrophages for Photodynamic Therapy Using AGuIX-Design Nanoparticles.
Lerouge L, Gries M, Chateau A, Daouk J, Lux F, Rocchi P
Pharmaceutics. 2023; 15(3).
PMID: 36986856
PMC: 10057379.
DOI: 10.3390/pharmaceutics15030997.
morphological alterations of TAMs during KCa3.1 inhibition-by using two-photon time-lapse technology.
Massenzio F, Cambiaghi M, Marchiotto F, Boriero D, Limatola C, DAlessandro G
Front Cell Neurosci. 2023; 16:1002487.
PMID: 36589283
PMC: 9798303.
DOI: 10.3389/fncel.2022.1002487.